MBX Biosciences, Inc. MBX Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Liquidity | ||||||
| Current ratio | 30.8×— | 24.6×— | 33×— | 19.5×— | —— | |
| Leverage | ||||||
| Debt-to-equity | 0×— | 0×— | 0×— | 0×— | —— | |
| Per Share | ||||||
| Book value per share | $9.40+33.4% | $10.11-58.2% | $11.33-72.8% | $6.55+108% | $7.05— | |
| Valuation | ||||||
| Market capitalization | $1.42B— | $1.42B— | $782.52M— | —— | —— | |
| Price / book | 3.2×— | 3.8×— | 2×— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do MBX Biosciences, Inc.'s ratios come from?
- Every ratio is computed from MBX Biosciences, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.